In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations
Open Access
- 23 November 2017
- journal article
- research article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 24 (1) , 88
Abstract
The arboviruses Zika virus (ZIKV) and Dengue virus (DENV) have important epidemiological impact in Brazil and other tropical regions of the world. Recently, it was shown that previous humoral immunity to DENV enhances ZIKV replication in vitro, which may lead to more severe forms of the disease. Thus, traditional approaches of vaccine development aiming to control viral infection through neutralizing antibodies may induce cross-reactive enhancing antibodies. In contrast, cellular immune response was shown to be capable of controlling DENV infection independently of antibodies. The aim of the present study was to design a flavivirus NS5 protein capable of inducing a cellular immune response against DENV and ZIKV. A consensus sequence of ZIKV NS5 protein was designed among isolates from various continents. Epitopes were predicted for the most prevalent alleles of class I and II HLA in the Brazilian population. Then, this epitopes were analyzed with regard to their conservation, population coverage and distribution along the whole antigen. Nineteen epitopes predicted to be more reactive (percentile rank <1) and 100% conserved among ZIKV and DENV serotypes were selected. The distribution of such epitopes along the protein was shown on a three-dimensional model and population coverage was calculated for different regions of the world. The designed protein was predicted to be stable and the distribution of selected epitopes was shown to be homogeneous along domains. The population coverage of selected epitopes was higher than 50% for most of tropical areas of the world. Such results indicate that the proposed antigen has the potential to induce protective cellular immune response to ZIKV and DENV in different human populations of the world.Keywords
Funding Information
- International Society for Infectious Diseases (001)
This publication has 19 references indexed in Scilit:
- Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis modelVirology, 2016
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic DiseaseNew England Journal of Medicine, 2015
- The Human CD8 + T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved EpitopesJournal of Virology, 2015
- The global distribution and burden of dengueNature, 2013
- Differential Targeting of Viral Components by CD4+versus CD8+T Lymphocytes in Dengue Virus InfectionJournal of Virology, 2013
- Dynamics of cellular immune responses in the acute phase of dengue virus infectionArchives of Virology, 2013
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony MethodsMolecular Biology and Evolution, 2011
- The Cellular Immune Response Plays an Important Role in Protecting Against Dengue Virus in the Mouse Encephalitis ModelViral Immunology, 2009
- Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman PrimatesJournal of Virology, 2004
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001